Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Granulomatous Dermatitis in a Patient With Cholangiocarcinoma Treated With BRAF and MEK Inhibitors.

Cutis - 1 Sept 2023

Bormann Jordan L, Kerkvliet Amy M

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Autoimmune Diseases
Share to Cholangiocarcinoma
Share to Dermatitis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Melanoma

Share to Mitogen-Activated Protein Kinase Kinases

Share to Protein Kinase Inhibitors

Share to Proto-Oncogene Proteins B-raf

Source

Identifiers

PMID: 37903392
DOI: 10.12788/cutis.0859

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Granulomatous Dermatitis in a Patient With Cholangiocarcinoma Treated With BRAF and MEK Inhibitors.PMID 37903392Read ↗

BRAF inhibition and the spectrum of granulomatous reactions.Semantic proximity Read ↗

Granuloma Annulare Secondary to Vemurafenib Therapy for Lung Adenocarcinoma.Semantic proximity Read ↗

Calciphylaxis as a Rare Complication Associated with Pemigatinib Treatment—A Case ReportSemantic proximity Read ↗

Case Report: Immune-Related Toxicity During Adjuvant Treatment With BRAF Plus MEK Inhibitors in a Melanoma Patient.Semantic proximity Read ↗

A case of generalized granuloma annulare treated with upadacitinibSemantic proximity Read ↗

Novel cutaneous effects of combination chemotherapy with BRAF and MEK inhibitors: a report of two cases.Semantic proximity Read ↗

Sarcoid-like reaction in a child following prolonged therapeutic exposure to dabrafenib and trametinib for BRAF V600E mutated hypothalamic/chiasmatic glioma.Semantic proximity Read ↗

Successful Management of Suspected Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in BRAF-Mutant Cholangiocarcinoma Following Treatment With Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors: A Case Report.Semantic proximity Read ↗

Research letter: BRAF-inhibitor induced panniculitis - A systematic review.Semantic proximity Read ↗

High prevalence of BRAFV600E in patients with cholestasis, sclerosing cholangitis or liver fibrosis secondary to Langerhans cell histiocytosis.Semantic proximity Read ↗

Impact of BRAF and MEK Inhibitors on Gingival Hyperplasia in Melanoma PatientsSemantic proximity Read ↗

The Growing Spectrum of Cutaneous RASopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.